Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Armandi

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Biology|January 21, 2023
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma DevelopmentGian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
The American Journal of Gastroenterology|April 14, 2025
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter StudyGian Paolo Caviglia, Arianna Ferro, Roberta D'Ambrosio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseChiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Biology|January 21, 2023
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma DevelopmentGian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
The American Journal of Gastroenterology|April 14, 2025
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter StudyGian Paolo Caviglia, Arianna Ferro, Roberta D'Ambrosio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseChiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Pageof 13